论文信息 - Dual Targeting Anticancer Theragnostic Strategy: a Generalized Approach?

Dual Targeting Anticancer Theragnostic Strategy: a Generalized Approach?

Poster: "ECR 2010 / C-0246 / Dual targeting anticancer theragnostic strategy: A generalized approach?" by: "Y. Ni1, Z. Sun2, J. Li1, F. Chen1, J. Zhang3, P. de Witte1, J. Nuyts1, A. Verbruggen1, G. Marchal1; 1Leuven/BE, 2Jinan/CN, 3Nanjing/CN"

[1] Yicheng Ni,et al. Metalloporphyrins and Functional Analogues as MRI Contrast Agents , 2008 .

[2] C. Sessa,et al. AVE8062: a new combretastatin derivative vascular disrupting agent , 2009, Expert opinion on investigational drugs.

[3] M. Stratton,et al. The cancer genome , 2009, Nature.